Study to Evaluate Different Regimens of Vaniprevir (MK7009) for the Treatment of Chronic Genotype 1 Hepatitis C Virus Infection in Treatment-naive Patients (MK-7009-019)(WITHDRAWN)

Inclusion Criteria: * Patient has chronic genotype 1 HCV infection * Patient has had a liver biopsy without evidence of cirrhosis * Patient has had an eye exam prior to the start of study * Female patients capable of having children and male patients with female partners capable of having children agree to use two forms of birth control throughout the study Exclusion Criteria: * Patient has had previous treatment with: 3 or more doses IFN, peg-IFN, and/or RBV; and stopped treatment due to intolerance of one of the drugs; other antiviral or investigational therapies or vaccines for HCV * Female patient is pregnant or breastfeeding * Patient has chronic hepatitis not caused by HCV * Patient has evidence of cirrhosis of the liver * Patient has HIV * Patient has active hepatitis B infection * Patient has non-genotype 1 HCV infection * Patient consumes excessive amounts of alcohol